Publications by authors named "Manuel Alva"

Claim this Profile
C
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations.
Noelia Martinez-Jañez, José Ángel García-Saenz, Sonia Pernas, Begoña Bermejo, Serafín Morales, Manuel Alva

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.
Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, Elia Seguí, Esther Carcelero, Manuel Alva

NPJ Breast Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy outcomes of CDK4/6 inhibitors in combination with endocrine therapy treatment in hormone receptor-positive/HER2-negative advanced breast cancer according to PAM50 intrinsic subtype: Primary results of SOLTI-1801 CDK-PREDICT study.
Pablo Tolosa, Tomás Pascual, Olga Martínez-Saez, Cristina Hernando, Sonia Servitja, Manuel Alva, Fernando Salvador

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proactive assessment of patient reported outcomes in ovarian cancer studies: a systematic review and call for action in future studies.
Ainhoa Madariaga, Rodrigo Sánchez-Bayona, Lawrence Kasherman, Jose Manuel Estrada-Lorenzo, Luis Manso, Manuel Alva

Int J Gynecol Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Rodrigo Sánchez-Bayona, Alfonso Lopez de Sa, Yolanda Jerez Gilarranz, Ana Sanchez de Torre, Manuel Alva, Salvador Gamez Casado

Breast Cancer Res Treat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the association of HER-2 low carcinomas and PAM50 assay in hormone receptor positive early-stage breast cancer.
Santiago Terán, Manuel Alva, Pablo Tolosa, Macarena Rey-Cárdenas, Ainhoa Madariaga

Breast· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
Antonio Calles, María Inmaculada Aparicio, Manuel Alva, Marianela Bringas, Natalia Gutierrez

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations.
Yolanda Jerez, Ivan Márquez-Rodas, Inmaculada Aparicio, Manuel Alva, Miguel Martín

Drugs· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticular activating system of a central pattern generator: premovement electrical potentials.
Jesus A Tapia, Argelia Trejo, Pablo Linares, J Manuel Alva, Rumyana Kristeva

Physiol Rep· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection.
Pramila Venigalla, Bharat Motwani, Sandra Allen, Manoj Agarwal, Manuel Alva

Blood· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis